Q3 pharma earnings roundup: AbbVie, Sanofi and Gilead report financials

AbbVie confirmed the midpoint of its full year adjusted EPS guidance range and declared a dividend increase of 5%.

Related Keywords

Paul Hudson ,Lauraj Schumacher ,Richarda Gonzalez ,Tommy Bracco , ,Specialty Care ,General Medicines ,